NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your Cassava Sciences, Inc. (NASDAQ:SAVA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/cassava-sciences-inc-lawsuit-submission-form?prid=128562&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your ModivCare Inc. (NASDAQ:MODV) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/modivcare-inc-lawsuit-submission-form?prid=128563&wire=1 or contact Joseph E. Levi, Esq.

SAN DIEGO, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers of ICON PLC (NASDAQ: ICLR) ordinary shares between July 27, 2023 and October 23, 2024, inclusive (the “Class Period”), have until April 11, 2025 to seek appointment as lead plaintiff of the ICON class action lawsuit. Captioned Shing v. ICON plc, No. 25-cv-00763 (E.D.N.Y.), the ICON class action lawsuit charges ICON and certain of ICON's top executive officers with violations of the Securities Exchange Act of 1934.

NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your Cardlytics, Inc. (NASDAQ:CDLX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/cardlytics-lawsuit-submission-form?prid=128565&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your ESSA Pharma Inc. (NASDAQ:EPIX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/essa-pharma-inc-lawsuit-submission-form?prid=128564&wire=1 or contact Joseph E. Levi, Esq.

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX ) Q4 2024 Earnings Conference Call February 10, 2025 4:30 PM ET Company Participants Susie Lisa - Senior Vice President, Investor Relations Reshma Kewalramani - President and Chief Executive Office Stuart Arbuckle - Chief Operating Officer Charlie Wagner - Chief Financial Officer Conference Call Participants Salveen Richter - Goldman Sachs Evan Seigerman - BMO Capital Markets Jessica Fye - JPMorgan Geoff Meacham - Citibank Michael Yee - Jefferies William Pickering - Bernstein Liisa Bayko - Evercore ISI Phil Nadeau - TD Cowen Eliana Merle - UBS Tazeen Ahmad - Bank of America Dave Risinger - Leerink …

iShares Core Dividend Growth ETF offers diversified exposure to high-quality companies with potential for dividend growth, making it a strong long-term core position. DGRO's strategy focuses on diverse sector allocations, emphasizing technology, financials, and healthcare, which enhances capital appreciation and provides resilience in downward markets. Despite a low starting yield, DGRO's consistent dividend growth, supported by net investment income, offers a growing income stream and stability through market shifts.

Mitek Systems, Inc. (NASDAQ:MITK ) Q1 2025 Earnings Conference Call February 10, 2025 5:00 PM ET Company Participants Todd Kehrli - Investor Relations, PondelWilkinson Ed West - Chief Executive Officer Dave Lyle - Chief Financial Officer Conference Call Participants Jake Roberge - William Blair Mike Grondahl - Northland Securities Allen Klee - Maxim Group Surinder Thind - Jefferies Operator Good afternoon, and welcome to the Mitek Fiscal 2025 First Quarter Earnings Conference Call. All participants will be in listen-only mode.

NEW YORK, NY / ACCESS Newswire / February 10, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Napco Security Technologies, Inc. ("Napco Security Technologies, Inc.") (NASDAQ:NSSC) concerning possible violations of federal securities laws. On February 3, 2025, news website Investing.com published an article entitled "NAPCO Security stock tumbles after Q2 sales decline.

CONSHOHOCKEN, Pa. , Feb. 10, 2025 /PRNewswire/ -- Private markets asset management firm Hamilton Lane Incorporated (Nasdaq: HLNE) ("Hamilton Lane") today announced the pricing of an underwritten public offering by Hamilton Lane and a selling stockholder of 1,572,536 shares of Class A common stock, in the aggregate, for gross proceeds of approximately $252 million.

NEW YORK, NY / ACCESS Newswire / February 10, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Crocs, Inc. (NASDAQ:CROX) between November 3, 2022 and October 28, 2024, inclusive (the "Class Period"), of the important March 24, 2025 lead plaintiff deadline. SO WHAT: If you purchased Crocs common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your Monolithic Power Systems Inc. (NASDAQ:MPWR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/monolithic-lawsuit-submission-form?prid=128554&wire=1 or contact Joseph E. Levi, Esq.

National Storage Affiliates is a storage REIT with 66% exposure to the Sunbelt region. The company only has 5% floating rate debt, which coupled with ongoing refinancing of fixed-rate debt indicates little benefits from Fed rate cuts. That said, occupancy appears to be stabilizing, which could allow net operating income to return to growth in 2025.

In today's video, I will be talking about recent updates regarding Super Micro Computer (SMCI 17.56%). Watch the short video to learn more, consider subscribing, and click the special offer link below.

NEW YORK CITY, NY / ACCESS Newswire / February 10, 2025 / WHY: New York, N.Y., February 10, 2025.

Lattice Semiconductor Corporation (NASDAQ:LSCC ) Q4 2024 Earnings Conference Call February 10, 2025 5:00 PM ET Company Participants Rick Muscha - Senior Director of IR Ford Tamer - CEO Tonya Stevens - Chief Accounting Officer and Former Interim CFO Lorenzo Flores - CFO Conference Call Participants Melissa Weathers - Deutsche Bank David Williams - The Benchmark Company Ruben Roy - Stifel Nick Doyle - Needham and Company Duksan Jang - Bank of America Joshua Buchalter - TD Cowen Srini Pajjuri - Raymond James Quinn Bolton - Needham and Company Operator Greetings and welcome to the Lattice Semiconductor Fourth Quarter Fiscal …

Harmonic Inc. (NASDAQ:HLIT ) Q4 2024 Results Conference Call February 10, 2025 5:00 PM ET Company Participants David Hanover - Investor Relations Nimrod Ben-Natan - President & Chief Executive Officer Walter Jankovic - Chief Financial Officer Conference Call Participants Simon Leopold - Raymond James Ryan Koontz - Needham Steven Frankel - Rosenblatt Securities Tim Savageaux - Northland Capital Markets Operator Welcome to the Fourth Quarter and Full Year 2024 Harmonic Earnings Conference Call. My name is Victor, and I will be your operator for today's call.

NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your Transocean Ltd. (NYSE:RIG) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/transocean-ltd-lawsuit-submission-form?prid=128548&wire=1 or contact Joseph E.

NEW YORK, NY / ACCESS Newswire / February 10, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of GeneDx Holdings Corp. ("GeneDx Holdings Corp.") (NASDAQ:WGS) concerning possible violations of federal securities laws. Grizzly Research ("Grizzly") published a report on February 5, 2025, entitled "Insiders Attest That GeneDx (Nasdaq: WGS) Is Actively Committing Widespread Fraud".

NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/regeneron-pharmaceuticals-inc-lawsuit-submission-form?prid=128551&wire=1 or contact Joseph E. Levi, Esq.